Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis.
Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, Mehrabi H, Khalaj A, Esmaeili R, Foroumadi A. Faraji A, et al. Among authors: hasanvand z. Eur J Med Chem. 2021 Jan 1;209:112942. doi: 10.1016/j.ejmech.2020.112942. Epub 2020 Oct 15. Eur J Med Chem. 2021. PMID: 33328104
Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity.
Faraji A, Motahari R, Hasanvand Z, Oghabi Bakhshaiesh T, Toolabi M, Moghimi S, Firoozpour L, Boshagh MA, Rahmani R, Ketabforoosh SHME, Bijanzadeh HR, Esmaeili R, Foroumadi A. Faraji A, et al. Among authors: hasanvand z. Bioorg Chem. 2021 Mar;108:104553. doi: 10.1016/j.bioorg.2020.104553. Epub 2020 Dec 13. Bioorg Chem. 2021. PMID: 33376012
Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942].
Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, Mehrabi H, Khalaj A, Esmaeili R, Foroumadi A. Faraji A, et al. Among authors: hasanvand z. Eur J Med Chem. 2021 Mar 15;214:113228. doi: 10.1016/j.ejmech.2021.113228. Epub 2021 Feb 4. Eur J Med Chem. 2021. PMID: 33550180 No abstract available.
Thienopyrimidine-based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity.
Mohammadian E, Oghabi Bakhshaiesh T, Jouyban A, Nazeri E, Hasanvand Z, Moghimi S, Motahari R, Firoozpour L, Bijanzadeh H, Alizadeh Sani M, Hosseinzadeh E, Esmaeili R, Foroumadi A. Mohammadian E, et al. Among authors: hasanvand z. Arch Pharm (Weinheim). 2023 Mar;356(3):e2200349. doi: 10.1002/ardp.202200349. Epub 2022 Nov 21. Arch Pharm (Weinheim). 2023. PMID: 36408898
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies.
Hasanvand Z, Oghabi Bakhshaiesh T, Peytam F, Firoozpour L, Hosseinzadeh E, Motahari R, Moghimi S, Nazeri E, Toolabi M, Momeni F, Bijanzadeh H, Khalaj A, Baratte B, Josselin B, Robert T, Bach S, Esmaeili R, Foroumadi A. Hasanvand Z, et al. Bioorg Chem. 2023 Apr;133:106383. doi: 10.1016/j.bioorg.2023.106383. Epub 2023 Jan 20. Bioorg Chem. 2023. PMID: 36764231
11 results